TALLC is an emerging ophthalmic medicines company focused on the unmet needs of patients with Progressive Kerotoconus. TALLC's unique combination of NCE drugs and enabling technologies can improve outcomes for this orphan indication while also addressing the needs of those with presbyopia or suffering from dry-eye syndrome.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 500 Boulevard Cartier O, Laval,quebec H7v 5b7,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- tallcinc.com
- HQ
- Laval, Quebec
Tallc Corporation Questions
Tallc Corporation's website is tallcinc.com
Tallc Corporation's LinkedIn profile is https://ca.linkedin.com/company/tallc-corporation
Tallc Corporation has
5 employees.
View email and phone details for 5
employees at Tallc Corporation.
Tallc Corporation's industry is
Pharmaceutical Manufacturing
Tallc Corporation's top competitors are
Altus Drug Development,
Assurart Inc.,
Altus Formulation Inc.,
Łukasiewicz – Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego,
Canndoc,
Erregierre Spa,
Biotech City,
Danaher Sensors And Controls,
Spektus Pharma,
Joinhub Gulf Pharma.
Tallc Corporation's categories are Pharmaceutical Manufacturing
Tallc Corporation's founding year is 2020
